Background-Angiotensin-converting enzyme inhibitors (ACEI) are a common cause of druginduced angioedema in the United States. Most epidemiologic ACEI angioedema data are from large multi-center clinical trials.
These findings underline the urgent need for more efforts to provide more accurate and relevant drug allergy alerts to help reduce alert override rates and improve alert fatigue.
Accurate electronic health records are important for clinical care and research as well as ensuring patient safety. It is crucial for misspelled words to be corrected in order to ensure that medical records are interpreted correctly. This paper describes the development of a spelling correction system for medical text. Our spell checker is based on Shannon's noisy channel model, and uses an extensive dictionary compiled from many sources. We also use named entity recognition, so that names are not wrongly corrected as misspellings. We apply our spell checker to three different types of free-text data: clinical notes, allergy entries, and medication orders; and evaluate its performance on both misspelling detection and correction. Our spell checker achieves detection performance of up to 94.4% and correction accuracy of up to 88.2%. We show that high-performance spelling correction is possible on a variety of clinical documents.
Background: Food allergy prevalence is reported to be increasing, but epidemiological data using patients' electronic health records (EHRs) remain sparse. Objective: We sought to determine the prevalence of food allergy and intolerance documented in the EHR allergy module. Methods: Using allergy data from a large health care organization's EHR between 2000 and 2013, we determined the prevalence of food allergy and intolerance by sex, racial/ethnic group, and allergen group. We examined the prevalence of reactions that were potentially IgE-mediated and anaphylactic. Data were validated using radioallergosorbent test and ImmunoCAP results, when available, for patients with reported peanut allergy. Results: Among 2.7 million patients, we identified 97,482 patients (3.6%) with 1 or more food allergies or intolerances (mean, 1.4 6 0.1). The prevalence of food allergy and intolerance was higher in females (4.2% vs 2.9%; P < .001) and Asians (4.3% vs 3.6%; P < .001). The most common food allergen groups were shellfish (0.9%), fruit or vegetable (0.7%), dairy (0.5%), and peanut (0.5%). Of the 103,659 identified reactions to foods, 48.1% were potentially IgE-mediated (affecting 50.8% of food allergy or intolerance patients) and 15.9% were anaphylactic. About 20% of patients with reported peanut allergy had a radioallergosorbent test/ImmunoCAP performed, of which 57.3% had an IgE level of grade 3 or higher. Conclusions: Our findings are consistent with previously validated methods for studying food allergy, suggesting that the EHR's allergy module has the potential to be used for clinical and epidemiological research. The spectrum of severity observed with
Background: Hypersensitivity reactions (HSRs) are immunologic responses to drugs. Identification of HSRs documented in the electronic health record (EHR) is important for patient safety. Objective: To examine HSR epidemiology using longitudinal EHR data from a large United States healthcare system. Methods: Patient demographic information and drug allergy data were obtained from the Partners Enterprise-wide Allergy Repository (PEAR) for two large tertiary care hospitals from 2000 to 2013. Drug-induced HSRs were categorized into immediate and delayed HSRs based on typical phenotypes. Causative drugs and drug groups were assessed. The prevalence of HSRs were determined, and sex and racial differences were analyzed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.